LSTA

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 1996, for Corniche Group Incorporated (noted as Lisata Therapeutics in metadata, but identified as Corniche Group in the filing text). The Company has been inactive since February 1996, following the appointment of receivers to its UK operating subsidiaries (Chessbourne International Limited and The Stationery Company Limited) and the holding company (Corniche Distribution Limited). These events resulted in the loss of all operations and operating assets, which are now classified as discontinued operations. The Company is currently seeking interim financing to settle liabilities and identify potential acquisitions.

Key Financial Metrics

Liquidity: The Company held only $449 in cash as of June 30, 1996. Current liabilities ($460,554) significantly exceed current assets ($90,449), indicating a severe working capital deficit. The Company was unable to meet liabilities as they fell due during the period but negotiated payment deferments with major creditors.

Material Changes vs. Prior Period

• Operating Loss Reduction: The operating loss decreased to $(32,250) from $(87,698) in the prior year quarter. This $55,448 reduction is attributed to significant decreases in insurance costs and professional fees.
• Discontinued Operations: The prior year period included a massive loss of $(1,285,234) from discontinued operations (the UK subsidiaries). The current period shows no activity from discontinued operations as the subsidiaries were removed from the balance sheet following receivership.
• Cash Flow: Net cash used in operating activities improved to a net inflow of $383 (driven by reductions in receivables and increases in payables) compared to a net outflow of $(556,694) in the prior year.
• Receivables: Notes Receivable decreased from $125,000 to $90,000 following a $35,000 principal payment received from Chester Holdings, Ltd.

Outlook, Risks, and Contingencies

Going Concern: The financial statements are prepared assuming the Company will continue as a going concern. However, management explicitly states that the ability to continue depends entirely on obtaining outside financing to support operations pending a suitable acquisition. There is no assurance such financing will be obtained.

Financing Activities: Subsequent to the reporting period, the Company engaged in two private offerings (July 1996–Dec 1996 and Jan 1997–Apr 1997) to raise capital via promissory notes and warrants. The first offering raised $100,000; the second sold 17 units.

Legal and Contingencies:

• Tax Delinquency: The Company is delinquent in filing Federal and State income tax returns for fiscal years 1994, 1995, and 1996.
• Debt Settlement: A $77,630 note payable to the Bank of Scotland (related to the UK receivership) was paid in full in January 1997, resulting in a mutual release of liabilities.
• Past Litigation: Class action lawsuits regarding revenue recognition irregularities were settled in 1994. A derivative action against former officers was dismissed in 1995, and a suit against the former CEO was settled in December 1996.

Investor Verification Checklist

• Capital Sufficiency: Verify if the Company has secured the necessary financing to avoid insolvency, given the $449 cash balance and $460k+ in current liabilities.
• Acquisition Status: Confirm if the Company has identified or completed a suitable acquisition to replace its lost operating assets.
• Tax Compliance: Investigate the status of the delinquent tax filings and potential penalties or interest accrued.
• Receivable Recovery: Assess the likelihood of recovering the remaining $75,000 balance on the Chester Holdings note, which is currently in negotiation for conversion to equity.
• Subsequent Offerings: Review the terms and success of the private securities offerings conducted in late 1996 and early 1997.